New: Introducing “Why Is It Moving?” - lightning-fast, AI-driven explanations of stock moves

Learn More
Last Close
Oct 16  •  04:00PM ET
81.37
Dollar change
+0.70
Percentage change
0.87
%
IndexS&P 500 P/E22.70 EPS (ttm)3.58 Insider Own0.15% Shs Outstand1.27B Perf Week6.03%
Market Cap103.20B Forward P/E11.36 EPS next Y7.16 Insider Trans-66.38% Shs Float1.27B Perf Month9.96%
Enterprise Value171.88B PEG1.58 EPS next Q1.37 Inst Own87.56% Short Float1.50% Perf Quarter31.33%
Income4.53B P/S0.27 EPS this Y17.54% Inst Trans0.93% Short Ratio2.42 Perf Half Y18.70%
Sales386.46B P/B1.33 EPS next Y12.46% ROA1.77% Short Interest18.94M Perf YTD81.27%
Book/sh61.07 P/C7.26 EPS next 5Y14.38% ROE5.95% 52W High81.93 -0.68% Perf Year20.62%
Cash/sh11.21 P/FCF21.59 EPS past 3/5Y-14.99% -6.37% ROIC3.04% 52W Low43.56 86.80% Perf 3Y-8.06%
Dividend Est.2.65 (3.25%) EV/EBITDA10.57 Sales past 3/5Y8.48% 7.75% Gross Margin13.78% Volatility2.41% 2.35% Perf 5Y36.99%
Dividend TTM2.66 (3.27%) EV/Sales0.44 EPS Y/Y TTM-36.28% Oper. Margin3.01% ATR (14)1.81 Perf 10Y-20.36%
Dividend Ex-DateOct 23, 2025 Quick Ratio0.62 Sales Y/Y TTM6.27% Profit Margin1.17% RSI (14)76.62 Recom1.47
Dividend Gr. 3/5Y9.07% 5.87% Current Ratio0.80 EPS Q/Q-42.82% SMA205.56% Beta0.59 Target Price84.88
Payout72.76% Debt/Eq1.07 Sales Q/Q8.34% SMA5010.77% Rel Volume0.87 Prev Close80.67
Employees300000 LT Debt/Eq0.93 EarningsOct 29 BMO SMA20024.53% Avg Volume7.82M Price81.37
IPOOct 01, 1952 Option/ShortYes / Yes EPS/Sales Surpr.24.14% 4.64% Trades Volume7,567,878 Change0.87%
Date Action Analyst Rating Change Price Target Change
Oct-14-25Initiated Goldman Buy $91
Aug-18-25Upgrade UBS Neutral → Buy $79
Aug-14-25Upgrade Robert W. Baird Neutral → Outperform $82
Feb-13-25Upgrade Leerink Partners Market Perform → Outperform $55 → $75
Feb-12-25Upgrade Cantor Fitzgerald Neutral → Overweight
Jan-30-25Upgrade Edward Jones Hold → Buy
Dec-03-24Upgrade Deutsche Bank Hold → Buy $66
Nov-18-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $66
Oct-10-24Upgrade Barclays Equal Weight → Overweight $63 → $82
Oct-04-24Upgrade TD Cowen Hold → Buy $59 → $85
Oct-16-25 09:40PM
07:07PM
05:09PM
01:16PM
01:10PM
10:19AM Loading…
10:19AM
09:50AM
09:40AM
08:50AM
03:15AM
03:01AM
02:02AM
Oct-15-25 07:48PM
03:16PM
01:52PM
12:10PM Loading…
12:10PM
11:36AM
10:54AM
10:00AM
09:41AM
09:15AM
08:31AM
08:00AM
07:10AM
Oct-14-25 09:44AM
08:58AM
08:00AM
Oct-13-25 08:44AM
08:39AM
Oct-11-25 01:33PM
10:00AM Loading…
10:00AM
Oct-10-25 05:45PM
Oct-09-25 05:51PM
05:24PM
09:49AM
09:30AM
09:00AM
Oct-07-25 10:00PM
12:08PM
09:40AM
09:00AM
Oct-06-25 04:15PM
Oct-03-25 11:05AM
Oct-02-25 06:18AM
Oct-01-25 05:45PM
07:00AM
Sep-30-25 02:49PM
02:21PM
10:20AM
09:00AM
Sep-25-25 10:01AM
09:50AM
09:00AM
Sep-23-25 05:45PM
10:36AM
10:31AM
08:59AM
08:23AM
Sep-22-25 01:11PM
01:01PM
10:14AM
09:35AM
07:00AM
Sep-19-25 04:00PM
09:40AM
08:46AM
Sep-18-25 04:40PM
08:37AM
Sep-17-25 05:09PM
02:07PM
12:20PM
12:12PM
11:26AM
Sep-16-25 11:01AM
Sep-15-25 05:45PM
01:48PM
05:05AM
Sep-13-25 01:49PM
Sep-12-25 05:37AM
Sep-11-25 01:01PM
11:52AM
09:00AM
08:22AM
Sep-10-25 10:29AM
09:25AM
09:00AM
09:00AM
Sep-09-25 04:49PM
04:30PM
01:38PM
09:50AM
09:30AM
Sep-08-25 06:12PM
05:34PM
03:36PM
01:10PM
11:26AM
08:39AM
06:05AM
Sep-04-25 08:35AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
CAPOZZI HEIDI BEVP and Chief People OfficerOct 23 '24Buy56.85351,99085Oct 14 07:08 PM
Finucane Anne A.DirectorAug 20 '25Sale71.027,500532,65022,156Aug 29 04:29 PM
Finucane Anne A.DirectorAug 20 '25Proposed Sale70.977,500532,275Aug 19 06:57 PM
SANSONE GUY PDirectorJun 05 '25Buy63.701,570100,00912,007Jun 09 08:22 AM
ROBBINS LARRYDirectorMay 02 '25Sale67.862,276,068154,444,7589,670,731May 06 04:15 PM
ROBBINS LARRYDirectorMay 05 '25Sale67.411,323,93289,249,9458,346,799May 06 04:15 PM
ROBBINS LARRYDirectorMay 06 '25Sale66.67150,00010,000,7108,196,799May 06 04:15 PM
Shah Prem SEVP and Group PresidentMar 17 '25Option Exercise62.2184652,63043,190Mar 18 04:51 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Option Exercise62.217,513467,38415,907Mar 07 04:56 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Sale66.357,513498,4888,394Mar 07 04:56 PM
Clark James DavidOfficerMar 05 '25Proposed Sale66.357,513498,489Mar 05 05:25 PM
Mahoney Michael FDirectorFeb 18 '25Buy66.7030,0002,001,00039,356Feb 19 12:35 PM